
News|Articles|March 1, 2002
Eligard 7.5 mg (Leuprolide acetate 7.5 mg for subcutaneous injection), Atrix/Sanofi-Synthelabo
New formulation: Monthly SC injection form of GnRH agonist for advanced prostate cancer
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Medicaid tech companies pledge $600 million to help states update systems
2
Myqorzo is now available for rare heart condition at a $108,400 annual price
3
FAQ: The uncertain future of enhanced ACA premium subsidies and what it means for U.S. healthcare
4
Why the great pharma-MedTech divide is healthcare’s biggest miss
5























